Target-treatment and patients' selection: can we still neglect the timing of tissue collection?
- PMID: 16135503
- DOI: 10.1200/JCO.2005.01.9174
Target-treatment and patients' selection: can we still neglect the timing of tissue collection?
Comment on
-
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources